Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 10,000 | 1,534 | 0 | 3 | 68 |
| Gross Profit | 10,000 | 1,534 | N/A | 3 | 68 |
| Operating Expenses | 48,942 | 40,986 | 31,055 | 29,755 | 30,347 |
| Operating Income | -38,942 | -39,452 | -31,055 | -29,752 | -30,279 |
| Other Income | 495 | 421 | 428 | 383 | 385 |
| Pre-tax Income | -38,447 | -39,031 | -30,627 | -29,369 | -29,894 |
| Income Tax | 12 | 9 | 13 | 18 | 23 |
| Net Income Continuous | -38,459 | -39,040 | -30,640 | -29,387 | -29,917 |
| Net Income | $-38,459 | $-39,040 | $-30,640 | $-29,387 | $-29,917 |
| EPS Basic Total Ops | -11.69 | -12.14 | -9.75 | -9.60 | -10.64 |
| EPS Basic Continuous Ops | -11.62 | -12.07 | -9.74 | -9.61 | -10.71 |
| EPS Diluted Total Ops | -11.69 | -12.14 | -9.75 | -9.60 | -10.64 |
| EPS Diluted Continuous Ops | -11.62 | -12.07 | -9.74 | -9.61 | -10.71 |
| EBITDA(a) | $-38,613 | $-38,994 | $-30,568 | $-29,247 | $-29,829 |